Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
Biomarker Insights, 2011 Objective In this prospective study we investigated the role of plasma levels of soluble urokinase plasminogen activator receptor (suPAR) in children with urinary tract infection.
Per Wittenhagen +7 more
doaj +3 more sources
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
PLoS ONE, 2019 BackgroundThe soluble urokinase plasminogen activator receptor (suPAR) is related to hepatic inflammation and fibrosis and has been suggested to participate in the development of liver cirrhosis. Therefore, the aim of the current study was to measure the
Emilie Garnæs +5 more
doaj +5 more sources
Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
PLoS ONE, 2014 ObjectivesInflammation is involved in the pathogenesis of depression. A few cross-sectional population-based studies have found that depression is associated with increased levels of inflammatory markers. Soluble urokinase plasminogen activation receptor
Eva Haastrup +5 more
doaj +5 more sources
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD [PDF]
Respiratory Research, 2018 Background The inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is elevated in severe acute and chronic medical conditions and has been associated with short-term mortality.
Nina S. Godtfredsen +6 more
doaj +4 more sources
The Diagnostic Value of Soluble Urokinase Plasminogen Activator Receptor in Crimean-Congo Hemorrhagic Fever Disease in Emergency Department [PDF]
Düzce Tıp Fakültesi Dergisi, 2021 Aim: The urokinase-type plasminogen activator (uPA) system consists of a protease, a receptor (urokinase-type plasminogen activator receptor, uPAR), and inhibitors that can be expressed on various cell types.
Mahmut Şenyurt +6 more
doaj +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018 BackgroundType 2 diabetes mellitus is a major risk factor for cardiovascular disease; however, outcomes in individual patients vary. Soluble urokinase plasminogen activator receptor (suPAR) is a bone marrow–derived signaling molecule associated with ...
Salim S. Hayek +7 more
doaj +3 more sources
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia [PDF]
ERJ Open Research, 2019 Introduction Diagnosing ventilator-associated pneumonia (VAP) remains challenging. Soluble urokinase plasminogen activator receptor (suPAR) has prognostic value in critically ill patients with systemic infection.
Pouline M. van Oort +7 more
doaj +6 more sources
Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation [PDF]
Blood Advances: Acute kidney injury (AKI) frequently follows hematopoietic cell transplantation (HCT). Soluble urokinase-type plasminogen activator receptor (suPAR) is a biomarker of AKI in the general population.
Bhavna Bhasin-Chhabra +7 more
doaj +2 more sources
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation [PDF]
Frontiers in Immunology, 2021 Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation that plays a major role in immunosenescence and in development and progression of many diseases.
Line Jee Hartmann Rasmussen +3 more
doaj +3 more sources
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
Caspian Journal of Internal Medicine, 2022 Background: The biomarker soluble urokinase plasminogen activator receptor (suPAR) is an indicator of inflammation which is increased in a variety of chronic and acute disease states.
Dimitrios Velissaris +4 more
doaj +3 more sources